BRAF p.V600E or equivalent molecular alterations (BRAF V600E-like signature) are the 'early/driver' events in the development of conventional papillary carcinoma (Figs 1 and 2 and Table 2). This evidence concerns the gene BRAF and thyroid gland papillary carcinoma.